Abstract
Ethical Viewpoint Paper_Benefit, Harm and the COVID-19 Pandemic: A Medical Student's Perspective
Highlights
COVAX- A Global Initiative (Sharing of Benefits) Across the world, people are responding to the global health crisis caused by the COVID-19 pandemic
Governments, researchers, and scientists are working in unison for the common good. One such global initiative is COVAX. It is co-led by the Coalition for Disease Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO), working in cooperation with developed and developing country vaccine manufacturers
That convalescent plasma is not effective in improving mortality or clinical improvement is uncertain in patients with COVID-19 disease [4-6]
Summary
COVAX- A Global Initiative (Sharing of Benefits) Across the world, people are responding to the global health crisis caused by the COVID-19 pandemic. Researchers are incessantly trying to develop methods to combat the deleterious effects of COVID-19 disease on the people. One of the latest developments in treating severe or life-threatening COVID-19 disease is convalescent plasma therapy. That convalescent plasma is not effective in improving mortality or clinical improvement is uncertain in patients with COVID-19 disease [4-6].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
